Prenatal Cell & Gene Therapy

Responsible for planning an Annual Meeting symposium and other on-line seminars, highlighting the advancements of cell and gene therapy and other related approaches to treat genetic diseases prior to birth. The committee will address matters pertaining to basic and translational science investigating age-appropriate cell therapies, developing age-safe gene delivery systems, and gaining a full understanding of the risks and benefits of employing current therapeutics to the fetal population. It is the goal of this committee to promote research that can fill critical gaps in knowledge in fetal therapies and create paths to bring these therapies to fruition.
Full NamePositionOrganizationTerm StartTerm End
Christopher D. Porada, PhDChairWake Forest Institute for Regenerative Medicine6/1/20255/31/202728938
Tippi C. MacKenzie, MDMemberUniversity of California San Francisco2/1/20235/31/202935356
Rafael J. Yanez-Munoz, PhDMemberRoyal Holloway University of London2/1/20235/31/202912701
Agnieszka Czechowicz, MD, PhDMemberStanford University, School of Medicine2/1/20235/31/202922041
Panicos Shangaris, MSc, MRCOG, PhDMemberKing's College London6/1/20255/31/202827820
Afrooz Rashnonejad, PhDMemberJerry R. Mendell Center for Gene Therapy, Nationwide Children's Hospital2/1/20235/31/202928743
Agnes Jaulent, PhDMemberEspeRare Foundation6/1/20255/31/2028104721
Alice F. Tarantal, PhDMemberUniversity of California, Davis2/1/20235/31/20294029
Suchit Sahai, Dr., PhDMemberKite Pharma6/1/20245/31/202767701
Lluis Samaranch, PhDMemberThe Ohio State University2/1/20235/31/202921402
Ritu RamamurthyMemberWake Forest Institute for Regenerative Medicine6/1/20255/31/202836131
M Graça D. Almeida-Porada, MD, PhDMemberWake Forest School of Medicine6/1/20255/31/202924792
Danielle GaleStaff LiaisonASGCT2/1/20235/31/204535359